Biodegradable nitrile gloves: what the claim means and how to verify it
“Biodegradable” is one of the least regulated words in glove marketing. What the claim rests on, our tested figures, and five questions that separate testing from marketing.
"Biodegradable" is one of the least regulated words in glove marketing. There is no single standard a glove must meet to use it, no required disclosure of test conditions, and no obligation to state a rate. A buyer who accepts the word without the numbers has bought nothing verifiable.
This article covers what the claim rests on, what our own figures are, and the five questions that separate a tested claim from a marketing one.
The problem it addresses
Conventional nitrile is a synthetic elastomer. In landfill it persists, on commonly cited estimates, for 100 to 200 years. Global glove consumption runs to hundreds of billions of units a year, and almost all of it is single-use.
Incineration with energy recovery is a legitimate route where the infrastructure exists, and for clinically contaminated waste it is the required one. But large volumes of glove waste from non-clinical use – food handling, laboratory, industrial, care settings – go to landfill, and that is the waste stream a biodegradable formulation addresses.
How the formulation works
A biodegradable nitrile glove is not a different polymer. It is NBR compounded with an additive that makes the cured film accessible to microbial action.
Degradation proceeds in two stages. The outer surface erodes first, which exposes greater surface area and creates entry points. Micro-organisms then metabolise the exposed material, breaking the polymer chains into shorter fragments they can consume. The end products are biomass, water and gases.
The mechanical properties are unaffected in use. The additive acts under the anaerobic, microbially active conditions of landfill, not in a storeroom or on a hand. Our biodegradable glove meets the same EN 455 requirements as our conventional nitrile, with the same five-year declared shelf life.
Our numbers, and their conditions
Our Prosenso™ biodegradable nitrile glove is tested to ASTM D5511, with a result of 43.0 % biodegradation at 513 days.
Three things about that figure deserve stating plainly, because they are what an honest claim looks like:
It is a rate, not a completion date. 43 % at 513 days describes measured progress under test conditions. Any supplier quoting a single "fully biodegrades in X years" figure without a test method and a measurement interval is extrapolating.
ASTM D5511 uses high-solids anaerobic digestion conditions, which are more microbially active than an average landfill. This is a laboratory benchmark for comparing materials, not a prediction of behaviour in a specific waste facility. Real-world rates depend on moisture, temperature and microbial population.
The comparison that matters is relative. Against 100–200 years for conventional nitrile, a material showing 43 % degradation inside two years is a materially different product. That is the defensible claim.
For the difference between ASTM D5511 and D5526, and why the choice of method changes the number, see ASTM D5511 vs ASTM D5526. For carbon footprint rather than end-of-life, see how to read an LCA study.
The accelerator-free advantage
Our biodegradable glove is also accelerator-free by formulation – no thiurams, dithiocarbamates or mercaptobenzothiazoles, which are the leading identified cause of Type IV allergic contact dermatitis from gloves.
This is a separate benefit from biodegradability and worth noting because the two are often bundled. Biocompatibility is verified to ISO 10993-10 for primary skin irritation and skin sensitisation, both passed.
The practical result is one product that addresses an environmental requirement and an occupational health requirement at once, which for a buyer with both in their specification is simpler than sourcing two.
Five questions to ask any supplier
1. Which test method, and what result at what interval? ASTM D5511 or D5526, a percentage, and a number of days. Anything less is not a claim. 2. Is the test report available, from which laboratory? A percentage in a brochure is not a report. 3. Does the glove meet EN 455 and hold a medical device declaration? A biodegradable glove with degraded barrier performance is not a saving. 4. Is it accelerator-free, and by formulation or by extraction result? These are different claims; only formulation protects a sensitised wearer. 5. What is the declared shelf life, and does the additive affect it? Ours is five years, unchanged.
If a supplier cannot answer all five, the word on the box is doing all the work.
Where this sits in a procurement specification
Environmental criteria in public tenders increasingly carry real weight, and the risk is specifying an outcome that cannot be evidenced. Two lines work better than a general sustainability requirement:
Biodegradability demonstrated by test report to ASTM D5511 or ASTM D5526, stating the percentage biodegraded and the test duration.
Confirmation that biodegradability does not affect compliance with EN 455-1:2020+A2:2024, EN 455-2:2024 and EN 455-3:2023, or the declared shelf life.
That is verifiable, comparable between bidders, and cannot be met with a marketing statement.
Frequently asked questions
Does a biodegradable glove degrade in storage? No. The additive is active under the anaerobic, microbially rich conditions of landfill. Under normal storage – dry, dark, room temperature – the declared five-year shelf life applies exactly as it does to conventional nitrile. See storing nitrile gloves.
Can biodegradable gloves be used for clinical work? Yes. Ours is a Class I medical device under MDR 2017/745 and Category III PPE, meeting the same EN 455 and EN ISO 374 requirements as our conventional nitrile.
Is biodegradability useful if our waste is incinerated? For clinically contaminated waste, incineration is the required route and biodegradability is not the relevant property. The benefit applies to the substantial non-clinical volume that goes to landfill. Worth splitting the specification by waste stream rather than applying one requirement across all use.
Is it more expensive? There is a premium, and it is modest relative to the total cost of glove supply. The accelerator-free formulation is often the stronger part of the business case, because Type IV contact dermatitis has direct occupational health costs.
Key takeaways
Seventeen years sourcing and supplying medical gloves and PPE to governments, UN agencies, NGOs and healthcare systems. Writes on glove standards, quality management and responsible sourcing for institutional buyers, working from the source standards rather than secondary summaries.
View profile on LinkedIn
